DAFNA Capital Management as of June 30, 2018
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 75 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Loxo Oncology | 12.9 | $28M | 159k | 173.48 | |
Sage Therapeutics (SAGE) | 7.0 | $15M | 96k | 156.53 | |
Stereotaxis (STXS) | 4.9 | $11M | 14M | 0.77 | |
Aerie Pharmaceuticals | 4.2 | $8.9M | 132k | 67.55 | |
NxStage Medical | 4.0 | $8.5M | 306k | 27.90 | |
AtriCure (ATRC) | 4.0 | $8.5M | 315k | 27.05 | |
Alder Biopharmaceuticals | 2.9 | $6.3M | 396k | 15.80 | |
Akebia Therapeutics (AKBA) | 2.9 | $6.1M | 611k | 9.98 | |
Blueprint Medicines (BPMC) | 2.8 | $5.9M | 93k | 63.48 | |
Dex (DXCM) | 2.5 | $5.2M | 55k | 94.98 | |
Luminex Corporation | 2.4 | $5.0M | 170k | 29.53 | |
Ascendis Pharma A S (ASND) | 2.3 | $4.9M | 74k | 66.53 | |
Neurocrine Biosciences (NBIX) | 2.1 | $4.5M | 46k | 98.25 | |
Kura Oncology (KURA) | 2.0 | $4.4M | 240k | 18.20 | |
Immunomedics | 2.0 | $4.3M | 183k | 23.67 | |
Zogenix | 2.0 | $4.3M | 98k | 44.20 | |
Arena Pharmaceuticals | 1.9 | $4.2M | 95k | 43.60 | |
Cymabay Therapeutics | 1.9 | $4.0M | 295k | 13.42 | |
Galapagos Nv- (GLPG) | 1.8 | $3.7M | 41k | 92.17 | |
Radius Health Inc note 3.000% 9/0 | 1.7 | $3.7M | 4.0M | 0.93 | |
BioCryst Pharmaceuticals (BCRX) | 1.6 | $3.5M | 605k | 5.73 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.3 | $2.9M | 26k | 109.81 | |
Xenon Pharmaceuticals (XENE) | 1.3 | $2.7M | 294k | 9.20 | |
Achillion Pharmaceuticals | 1.3 | $2.7M | 948k | 2.83 | |
Vbi Vaccines | 1.2 | $2.6M | 935k | 2.75 | |
Menlo Therapeutics | 1.2 | $2.5M | 312k | 8.12 | |
Intec Pharma | 1.2 | $2.5M | 569k | 4.40 | |
Biotelemetry | 1.1 | $2.5M | 55k | 45.01 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.1 | $2.4M | 2.5M | 0.95 | |
Argenx Se (ARGX) | 1.0 | $2.1M | 26k | 82.85 | |
Scynexis | 1.0 | $2.1M | 1.3M | 1.64 | |
Cardiovascular Systems | 0.9 | $1.9M | 59k | 32.35 | |
Wave Life Sciences (WVE) | 0.9 | $1.8M | 48k | 38.25 | |
Ardelyx (ARDX) | 0.8 | $1.7M | 473k | 3.70 | |
Foamix Pharmaceuticals | 0.8 | $1.7M | 338k | 5.01 | |
Zafgen | 0.8 | $1.7M | 163k | 10.23 | |
Insulet Corp note 1.375% | 0.8 | $1.7M | 1.5M | 1.11 | |
Macrogenics (MGNX) | 0.8 | $1.6M | 78k | 20.65 | |
Applied Genetic Technol Corp C | 0.7 | $1.6M | 421k | 3.70 | |
Immune Design | 0.7 | $1.5M | 329k | 4.55 | |
Incyte Corporation (INCY) | 0.7 | $1.4M | 22k | 67.02 | |
Leap Therapeutics | 0.6 | $1.4M | 152k | 9.00 | |
Dicerna Pharmaceuticals | 0.6 | $1.3M | 110k | 12.25 | |
Natus Medical | 0.6 | $1.3M | 38k | 34.51 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.6 | $1.3M | 171k | 7.30 | |
Cara Therapeutics (CARA) | 0.6 | $1.2M | 63k | 19.15 | |
Johnson & Johnson (JNJ) | 0.5 | $1.1M | 9.4k | 121.38 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.5 | $1.1M | 213k | 5.20 | |
Minerva Neurosciences | 0.5 | $1.1M | 131k | 8.25 | |
ArQule | 0.5 | $1.0M | 189k | 5.53 | |
Novavax | 0.5 | $1.0M | 750k | 1.34 | |
Advaxis | 0.5 | $1.0M | 697k | 1.45 | |
Obseva Sa | 0.5 | $984k | 65k | 15.14 | |
Biohaven Pharmaceutical Holding | 0.4 | $929k | 24k | 39.53 | |
Sunesis Pharmaceuticals Inc Ne | 0.4 | $792k | 374k | 2.12 | |
Bluebird Bio (BLUE) | 0.3 | $628k | 4.0k | 157.00 | |
Neon Therapeutics | 0.3 | $630k | 50k | 12.60 | |
Galmed Pharmaceuticals | 0.3 | $595k | 50k | 11.90 | |
Aptinyx | 0.3 | $604k | 25k | 24.16 | |
Cytokinetics (CYTK) | 0.3 | $576k | 69k | 8.30 | |
Masimo Corporation (MASI) | 0.2 | $488k | 5.0k | 97.60 | |
Urogen Pharma (URGN) | 0.2 | $498k | 10k | 49.80 | |
Rigel Pharmaceuticals | 0.2 | $389k | 138k | 2.83 | |
BioTime | 0.2 | $374k | 182k | 2.06 | |
Radius Health | 0.1 | $295k | 10k | 29.50 | |
Beigene | 0.1 | $307k | 2.0k | 153.50 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.1 | $288k | 250k | 1.15 | |
Sol Gel Technologies (SLGL) | 0.1 | $270k | 35k | 7.71 | |
Kadmon Hldgs | 0.1 | $261k | 66k | 3.98 | |
Alder Biopharmaceuticals Inc convertible security | 0.1 | $260k | 250k | 1.04 | |
Translate Bio | 0.1 | $253k | 20k | 12.65 | |
Bellicum Pharma | 0.1 | $221k | 30k | 7.37 | |
Dermira | 0.1 | $212k | 23k | 9.22 | |
Neos Therapeutics | 0.1 | $172k | 28k | 6.25 | |
Forty Seven | 0.1 | $160k | 10k | 16.00 |